Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varada Anirudhan

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Medical Virology|January 21, 2021
Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19Varada Anirudhan, Hyun Lee, Han Cheng, et al.
Journal of Medical Virology|November 6, 2023
Influenza virus cell entry and targeted antiviral developmentMurong Zhu, Varada Anirudhan, Ruikun Du, et al.
Journal of Medical Virology|July 8, 2020
RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic targetYanyan Wang, Varada Anirudhan, Ruikun Du, et al.
Microbiology Spectrum|May 16, 2024
VLP-based model for the study of airborne viral pathogensMichael Caffrey, Nitin Jayakumar, Veronique Caffrey, et al.
Plos Pathogens|August 22, 2020
Modulation of hepatitis B virus pregenomic RNA stability and splicing by histone deacetylase 5 enhances viral biosynthesisTaha Y Taha, Varada Anirudhan, Umaporn Limothai, et al.
Virologica Sinica|September 23, 2023
Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitorMeiyue Dong, Yanyan Wang, Ping Li, et al.
Virologica Sinica|May 4, 2023
Optimization and applications of an in vivo bioluminescence imaging model of influenza A virus infectionsXiaojing Lin, Murong Zhu, Xiujuan Zhao, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Engineering Versatile Two-Dimensional Nanobody-Origami Architectures for Enhanced Antiviral ActivityTingjie Song, Jazmin Galván Achi, Varada Anirudhan, et al.
Journal of Medical Virology|June 10, 2025
Inhibition of Influenza Entry by Organosilicon CompoundsAleksandar Antanasijevic, Nicholas J Haferman, Amir Shimon, et al.
ACS Pharmacology & Translational Science|December 14, 2023
Identification of the Imidazo[1,2-<i>a</i>]pyrazine Derivative <b>A4</b> as a Potential Influenza Virus Nucleoprotein InhibitorPing Li, Han Ju, Yihong Xing, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Medical Virology|January 21, 2021
Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19Varada Anirudhan, Hyun Lee, Han Cheng, et al.
Journal of Medical Virology|November 6, 2023
Influenza virus cell entry and targeted antiviral developmentMurong Zhu, Varada Anirudhan, Ruikun Du, et al.
Journal of Medical Virology|July 8, 2020
RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic targetYanyan Wang, Varada Anirudhan, Ruikun Du, et al.
Microbiology Spectrum|May 16, 2024
VLP-based model for the study of airborne viral pathogensMichael Caffrey, Nitin Jayakumar, Veronique Caffrey, et al.
Plos Pathogens|August 22, 2020
Modulation of hepatitis B virus pregenomic RNA stability and splicing by histone deacetylase 5 enhances viral biosynthesisTaha Y Taha, Varada Anirudhan, Umaporn Limothai, et al.
Virologica Sinica|September 23, 2023
Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitorMeiyue Dong, Yanyan Wang, Ping Li, et al.
Virologica Sinica|May 4, 2023
Optimization and applications of an in vivo bioluminescence imaging model of influenza A virus infectionsXiaojing Lin, Murong Zhu, Xiujuan Zhao, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Engineering Versatile Two-Dimensional Nanobody-Origami Architectures for Enhanced Antiviral ActivityTingjie Song, Jazmin Galván Achi, Varada Anirudhan, et al.
Journal of Medical Virology|June 10, 2025
Inhibition of Influenza Entry by Organosilicon CompoundsAleksandar Antanasijevic, Nicholas J Haferman, Amir Shimon, et al.
ACS Pharmacology & Translational Science|December 14, 2023
Identification of the Imidazo[1,2-<i>a</i>]pyrazine Derivative <b>A4</b> as a Potential Influenza Virus Nucleoprotein InhibitorPing Li, Han Ju, Yihong Xing, et al.
Pageof 2